Joseph Kozlowski
Family Medicine · Lansing, MINPI 1366420432
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 472 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,956 and has fallen 85.0% since, to $443 in 2025. Among family medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 472 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$932
- Sanofi-aventis U.S. LLC$665
- AbbVie$647
- Amgen$502
- GSK$454
- plus $3K from 31 others
What the payments were for
- Food & beverage$7,45299%
- Education$481%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 120 | $1,560 |
| AstraZeneca | 21 | $932 |
| Sanofi-aventis U.S. LLC | 42 | $665 |
| AbbVie(2 entities) | 37 | $647 |
| Amgen(2 entities) | 37 | $502 |
| GSK | 39 | $454 |
| Teva Pharmaceuticals USA, Inc. | 34 | $314 |
| Pfizer | 18 | $235 |
| Johnson & Johnson | 17 | $235 |
| Bayer | 8 | $205 |
| Amarin Pharma, Inc. | 13 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $195 |
| Kowa Pharmaceuticals America, Inc. | 4 | $163 |
| Merck | 10 | $155 |
| Lilly USA, LLC | 10 | $145 |
| Biohaven Pharmaceuticals, Inc. | 8 | $129 |
| Novartis | 6 | $94 |
| Mylan Specialty L.p. | 5 | $85 |
| Esperion Therapeutics, Inc. | 4 | $81 |
| E.r. Squibb & Sons, L.L.C. | 3 | $42 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Dexcom, Inc. | 2 | $37 |
| IBSA Pharma Inc. | 2 | $36 |
| Sunovion Pharmaceuticals Inc. | 3 | $36 |
| Astellas Pharma US Inc | 2 | $35 |
| Eisai Inc. | 2 | $32 |
| Bardy Diagnostics, Inc. | 2 | $31 |
| Phadia US Inc. | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Ironshore Pharmaceuticals Inc. | 2 | $24 |
| Exact Sciences | 1 | $19 |
| Bioventus LLC | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Abbott | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,500 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 13 | $93 |
| Meloxicam | 13 | $60 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Lansing
- Farhan BhattiLansing$230K
- Laurie RozekLansing$86K
- Amy TrinhLansing$19K
- Rosemary RoperLansing$17K
- Mark SchaarLansing$16K
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.